share_log

ノイルイミューン・バイオテック---東京証券取引所グロース市場の貸借銘柄選定

Noil Immune Biotech --- Selection of loan stocks in the Tokyo Stock Exchange Growth Market.

Fisco Japan ·  Dec 25, 2024 16:47

Noir Immuno BioTech <4893> announced on the 20th that it has been newly selected as a borrowed stock on the Tokyo Stock Exchange Growth Market.

The company is an academia-based biotech that is working on the practical application of next-generation cancer immunotherapy for solid cancers with PRIME CAR-T cells equipped with PRIME technology, an innovative technology unique to the company that enhances the therapeutic effect of immune cell therapy.

The selection date is December 23, 2024 (Monday), and it will be implemented from the trades of that day.

This selection as a borrowed stock is expected to promote the liquidity and supply-demand relationship of the company's stocks, contributing to the activation of trading and the formation of fair prices.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment